Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
6.63
+0.30 (4.83%)
At close: Sep 18, 2026, 4:00 PM EDT
6.54
-0.08 (-1.27%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $25.27 million as of September 18, 2026. Its market cap has increased by 1,064.65% in one year.
Market Cap
25.27M
Enterprise Value
17.83M
1-Year Change
1,064.65%
Ranking
Category
Stock Price
$6.63
ChartMarket Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $25.27M, a decrease of -92.19%. That is a compound annual growth rate of -41.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 25.27M | 1,691.68% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 26.21M |
| NextCure | 25.95M |
| Atossa Therapeutics | 23.95M |
| Actuate Therapeutics | 23.90M |
| Polyrizon | 23.21M |
| Estrella Immunopharma | 22.88M |
| Cellectar Biosciences | 22.69M |
| TScan Therapeutics | 22.60M |